StockMarketWire.com - Pharmaceutical company AstraZeneca said it had priced a $3bn bond offering to fund general corporate purposes.
The three-tranched offering, expected to close on 6 August, included $1.2bn of fixed-rate notes with a coupon of 0.700%, maturing 8 April 2026; $1.3bn of fixed-rate notes with a coupon of 1.375%, maturing 6 August 2030; and $0.5bn of fixed-rate notes with a coupon of 2.125%, maturing 6 August 2050. Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.